Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
However, since Saxenda (liraglutide) became the first GLP-1 approved for weight loss in 2014, additional options like Wegovy (semaglutide) and Zepbound (tirzepatide) have also been approved for weight management
It activates the same GLP-1 pathway semaglutide uses, but it also targets glucose-dependent insulinotropic polypeptide (GIP) receptors
Research consistently shows that a significant portion of lost weight is regained when treatment is stopped
GLP-1 agonists and changes in body mass and composition in adults with overweight or obesity with or without type 2 diabetes mellitus: a systematic review and meta-analysis
US$ 29.18
US$ 22.29
US$ 22.17
US$ 28.65
US$ 22.05
US$ 25.57
